HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Agusti, A. Articles by Soriano, J. B. Search for Related Content PubMed Articles by Agusti, A. Articles by Soriano, J. B.

Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?

¹ Hospital Universitario Son Dureta, Palma de Mallorca, and ² Fundación Caubet-Cimera, Illes Balears, Spain.

CORRESPONDENCE: A. Agusti, Hospital Universitari Son Dureta, Andrea Doria 55, 07014 Palma de Mallorca, Spain. Fax: 34 971175228. E-mail: aagusti{at}hsd.es

In patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), end-expiratory lung volume increases under conditions of greater minute ventilation (e.g. exercise). This abnormal response is termed dynamic hyperinflation (DH) and has now been recognised as a key determinant of symptomatology and exercise intolerance in COPD. Reduced elastic recoil, loss of alveolar attachments and increased airway resistance are the mechanical factors traditionally invoked to explain the occurrence of DH in COPD. An abnormal inflammatory response to, most frequently, tobacco smoking is a key pathophysiological component of COPD, but its potential relationship with DH has not been directly investigated and is poorly understood. The present article discusses, first, the mechanisms by which DH can enhance inflammation in COPD (including cellular stretching, tissue damage and danger signals, hyperventilation and hypoxia). It then reviews how the abnormal inflammatory response that characterises the disease can augment DH (oedema and increased airway resistance, increased mucus production and alveolar destruction). Finally, it speculates that if these relationships eventually prove to be real, then the use of long-acting bronchodilators may help reduce the inflammatory load of these patients and, conversely, the use of anti-inflammatory therapy can contribute to the reduction of DH.

KEYWORDS: Bronchodilators, chronic bronchitis, dyspnoea, emphysema, exercise, steroids

This article has been cited by other articles:

				A. Agusti Physical Activity and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 675 - 676. [Full Text] [PDF]